Tuesday October 15, 2019

Good News for Cancer Patients, Treatments to be Less Invasive

Many people have some combination of chemo, radiation and surgery

0
//
cancer research
Several expert doctors from India, the US, the UK and specialists in the area of Computer Science from India participated in the panel discussions and presentations. Pixabay

There’s good news for cancer patients: Treatments are becoming less invasive and taking less time.

Traditional treatments often include chemotherapy or radiation to kill cancer cells and shrink tumors. The treatments kill healthy cells as well as cancerous ones, and the side effects are legendary.

Surgery can be an option, too. Sometimes it’s all that’s needed, but many people have some combination of chemo, radiation and surgery. These treatments can span months, and patients have months more of recovery time.

Cancer treatment is now moving toward precision medicine that targets just the cancer.

 Cancer, Patients, Invasive
There’s good news for cancer patients: Treatments are becoming less invasive and taking less time. Pixabay

For example, doctors are using focused radiation, after a lumpectomy, for women who have early stage breast cancer. With this procedure, radiation beams pinpoint the tumor from hundreds of different angles for a short period of time. Each beam itself is weak, but together, when they hit the tumor, the result is a higher dose of radiation.

Just five days

Dr. Julia White at the Ohio State University Comprehensive Cancer Center found focused radiation has the same positive results as full breast radiation. Plus, the partial radiation takes only five days.

White said, “The short five-day treatment is just as good as the whole breast irradiation [that lasts] for four to six weeks.”

Also Read- WHO Asks Ugandans with Ebola Contract to Trust Trial Vaccine

Other treatments use the body’s own immune system. Dr. William Nelson at Johns Hopkins Medicine told VOA it’s clear that the immune system sees cancer cells as abnormal, “and if we unleash the immune system, it can attack and destroy the cancer cells.”

The American Cancer Society says immunotherapy has become an important part of treating some cancers, and that newer types of immune treatments, currently being studied, will affect how we treat cancer in the future.

Still another new treatment, genomic testing, involves testing the cancer cells to determine their genetic makeup.

Most cancers start because of genetic mutations, and each patient’s cancer is unique, just like his or her DNA. If doctors know the particular DNA, they can prescribe medicine that targets the mutated cells. Healthy cells are left alone.

 Cancer, Patients, Invasive
Traditional treatments often include chemotherapy or radiation to kill cancer cells and shrink tumors. Pixabay

Dr. Marcia Brose at the Abramson Cancer Center at the University of Pennsylvania specializes in this type of treatment. In a Skype interview with VOA, she said genomic testing and precision medicine targets cancer cells “at the very core of what made them a cancer to begin with, and that’s what precision medicine is really about.”

Few side effects

Brose said few patients have any side effects. If they do, she lowers the dose of the medication. It eliminates the side effect, and the treatment is still effective.

Because genomic testing is costly, Brose said, the biggest impact right now is for patients whose cancer keeps returning or spreads to other parts of the body. She doesn’t see it yet as a first-line treatment. But the results are outstanding.

Also Read- YouTube Decides to Add More Controls for Home Page, Up Next Videos

Brose recalled treating a woman with a rare type of cancer called sarcoma. When they met, the patient was in a wheelchair and on oxygen. Brose said that three years after treatment, the woman is hiking with her kids.

Brose said that patients whose cancers aren’t responding to treatment should ask their doctors about genomic testing. It isn’t for everyone, but Brose and other cancer specialists think targeted therapy, immunotherapy or genomic testing and precision medicine are the future of cancer treatment. And one day, it will be the standard treatment worldwide. (VOA)

Next Story

Being Overweight Before the Age of 40 Can Increase Risk of Cancer in Adults

"The risk increased by 64 per cent for male participants and 48 per cent for females," Bjorge added

0
Cancer
Cancer Ribbon. Pixabay

Researchers have found that being overweight before the age of 40 could increase the risk of various cancers in adults.

“Obesity is an established risk factor for several cancers. In this study, we have focused on the degree, timing and duration of overweight and obesity in relation to cancer risk,” said study author Tone Bjorge, Professor at University of Bergen in Norway.

For the findings, published in the International Journal of Epidemiology, the research team wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer.

The researchers used data for 2,20,000 individuals from the Me-Can study, with participants from Norway, Sweden and Austria.

Data from health examinations, including information on height and weight, were linked to data from national cancer registries.

Obesity
An overweight woman sits on a chair in Times Square in New York, May 8, 2012. VOA

According to the researchers, 27,881 individuals were diagnosed with cancer during follow-up, of which 9,761 (35 per cent) were obesity-related.

The study showed that if you were overweight before age 40, the risk of developing cancer increases by: 70 per cent for endometrial cancer, 58 per cent for male renal-cell cancer, 29 per cent for male colon cancer and 15 per cent for all obesity-related cancers (both sexes).

Also Read: Google Maps Announce New Improvements with Enhanced Voice Guidance

Obese participants (BMI over 30) at the first and second health examination had the highest risk of developing obesity-related cancer, compared to participants with normal BMI.

“The risk increased by 64 per cent for male participants and 48 per cent for females,” Bjorge added. (IANS)